| Feb 22, 2022 |
Lauren Sciences Founder, Chairman & CEO Susan Rosenbaum and V-Smart® Platform are highlighted in Discussion Group Report, “Prominent Names in RNA Delivery Discuss What’s Around the Corner”, by Tom Cohen of Oxford Global. |
| Jan 19, 2021 |
Lauren Sciences discussed on the Ozy site here. |
| Sep 17, 2020 |
Lauren Sciences discussed on the FightMND site here.
and again here. |
| Jul 7, 2020 |
Lauren Sciences discussed in “Update on glioma biotechnology”, Boockvar JA et al., Clin Neurol Neurosurg. 2020 Jul 7;195:106075. |
| Feb 11, 2020 |
Lauren Sciences CEO Susan Rosenbaum was interviewed by Proactive Investors at BIO CEO & Investor Conference in New York on February 11, 2020. Lauren Sciences is privately-held New York-based biotechnology company developing V-Smart® Nanomedicines to treat brain diseases. Last year it was announced that Lauren Sciences was awarded AU $1M translational grant by Australian-based FightMND. See interview, “Lauren Sciences wins 4th grant for its ALS drug” |
| Jun 2, 2019 |
Lauren Sciences Won 1st Place at China Focus Global Healthcare Innovation Competition during BIO 2019 in Philadelphia, PA. |
| Apr 4, 2019 |
ALS News Today article on FightMND Awards Grant to Lauren Sciences to Develop Promising ALS Therapy. |
| Mar 1, 2019 |
$7.6m committed to new research projects during 2019 - FightMND |
| Mar 1, 2019 |
Neal Daniher's FightMND delivers seven new research projects - Herald Sun |
| Jul 25, 2018 |
BIO, biotechnology industry’s leading organization, announces Lauren Sciences as one of the winners at forum held during BIO’s 25th International Convention in June in Boston, MA. |
| Apr 18, 2018 |
Lauren Sciences Awarded Third Grant for Development of Potential ALS Therapeutic - The ALS Association Blog |
| Apr 11, 2018 |
Lauren Sciences LLC Awarded Grant from The ALS Association - AABGU |
| Mar 12, 2018 |
Lauren Sciences "V-Smart®: A Breakthrough Innovation" is cover feature of March 2018 issue of Drug Development & Delivery magazine. Article entitled, “V-Smart® Nanomedicines: Non-Invasive Targeted Brain Therapeutics for CNS Diseases”, is authored by Susan Rosenbaum, J.D. and Irwin Hollander, Ph.D. |
| Dec 1, 2017 |
The official blog of the ALS association on the highlights from the annual Society for Neuroscience meeting in Washington, D.C. |
| Jul 26, 2017 | Easier Way to Deliver Parkinson’s Medication - AABGU |
| Aug 8, 2015 | Campbell Foundation Funding: We See Results | Funding AIDS/HIV research | Fort Lauderdale| The Campbell Foundation |
| Jul 22, 2015 |
Labroots - Crossing the Blood Brain Barrier |
| Jul 2, 2015 | V-Smart® Technology Could Be the Answer to Brain Tumor Treatment - AABGU |
| May 5, 2015 | The ALS Association I Progress in Drug Development Reviewed at The ALS Association Drug Company Working Group Meeting |
| May 7, 2014 | Nano Drug Delivery for Parkinson’s - AABGU |
| May 5, 2014 | Vesicles Can Cross Blood Brain Barrier to Treat Central Nervous System Disorders - The Bio Science Technology |
| Jul 31, 2012 | BGU Scientists Overcome ‘Blood Brain Barrier’ - The Jerusalem Post |
| Apr 11, 2012 | New Hope for Parkinson’s and Other Central Nervous System Disease Sufferers - AABGU |
| Apr 10, 2012 | Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm |
